Sun. Aug 14th, 2022

There were many new biological drugs approved by the FDA to treat psoriasis since 2003 as one of these of an inflated drug price that many lower income people can’t obtain access to because Medicaid and Medicare won’t purchase them as a result of skyrocketing prices. The new blood thinner “Eliquis” is covered by Medicaid and Medicare at $200 a bottle. The COPD inhalers which are fairly new will also be covered by the federal government without hesitation in your community of $150 a pop. Some states purchase the very expensive $400 and above hearing aids and some don’t. So why aren’t the brand new biological drugs that arrived on the scene to treat psoriasis since 2003 covered by the federal government?

I guess this really is one moment where I’m going to answer the question I simply asked of this articles readers. In the above linked article I posted to go with this specific article the writer states these biological drugs to treat psoriasis will NOT be open to people that are on Medicaid and Medicare because of price. All of the drug companies who have created their very own biological psoriasis treatments have pushed people on Medicaid and Medicare away from receiving treatment with one of these drugs through the high cost of the drugs. Medicare Part D prescription drug plan will probably pay the bulk cost of “biological’s” however the co pay is between $1200 and $5000 which still keeps folks from having the biological’s.

The spin is a few of these biological drug companies have programs to provide the drugs absolve to low income patients who have private insurance only. Drug companies have stated in lots of articles I’ve read that if the patients have Medicare or Medicaid they’ll NOT be eligible for the free programs.

Quote From GoodRX.com: The lowest GoodRx price for the most typical version of Humira is just about $5,130.76, 38% off the common retail price of $8,309.04.

These biological psoriasis treatments are not life saving so Medicare and Medicaid don’t recognize the inflated cost by drug companies as a necessary expense. wocklean The drug companies know this and are interested this way. Back 2003 when these biological psoriasis treatments were entering the drug marketplace these were affordable and insurance companies acquired the expense if a reasonable deductible was paid. After 2012 the insurance companies started to get rid of people who have psoriasis as the payouts on the biological treatments were increasing and getting extremely expensive.
The “Epipen Injector” used to treat heroin overdoses was attacked viciously by the U.S. government when who owns the company jacked up the purchase price so high only the really wealthy could afford them. Medicaid and Medicare in a few states do cover generic Epipen’s but reject brand names. I’ve arrived at my conclusion about why this and other high drug prices are happening that keep many of these drugs out of the reach of many people that are on Medicare and Medicaid.

Come ON! obviously it’s collusion between the “Big Pharma” drug industry and members of congress. But once the collusion deals go bad it’s the drug industry that’s forced to take the fall.

When these scams to gain personal wealth arrived at light as in the opioid epidemic that’s ongoing now where billions of dollars are being paid out by the drug companies to the states our congressional representatives who profited from opioids though insider trading investments walk around without any possibility of repercussion because of their involvement in the scheme.

If you look at Canada which really is a country where government has to fund ALL healthcare costs you will dsicover the best prices on quality drugs anywhere because the federal government forces prices down to reduce government expenditures. All of the drug companies that come up with high profit drug plans to fill their pockets are destroyed without question by the Canadian government. In the U.S. our congressional representatives steer thought away from destroying excessive profit taking by the drug companies as they are committed to these drug companies for their very own personal profit. Congressional Representatives enter congress with meager wealth and leave with excessive riches.

I simply bet ya if a person gained use of the investments of our congressional leaders they’d find many cases of drug company investments who have very high drug prices on popular needed drugs that really work to enhance a persons health. Congress voted to provide drug companies a 20 year patent before generics might be produced with a 5 year extension if certain conditions are met understanding that high drug prices would develop giving congressional insiders great profit making investment opportunities.

I hear now and again on news shows the patent time is now 12 years but I haven’t seen this 12 year patent time frame in “Wikipedia” or anywhere else. All I see are 20 year patent time frames. I searched around and learned following the drug is invented and a patent applied it may take around 8 years to get FDA approved which leaves 12 years for the drugs to stay on a patent.

Which of our congressional representatives would vote against this time honored tradition of screwing U.S. Citizens in the behind by increasing patent times so they may increase their very own personal cash value through outrageous drug prices?

So lets take the biological psoriasis drugs as an example since they’ve only been around since 2003 or so. “Humira” was the very first biological patent approved by the FDA for the treating Rheumatoid Arthritis. Afterwards “Humira” was approved for the treatments of several other medical conditions including psoriasis.

If there is a 20 year patent on these drugs then “Humira” is likely to be priced out of reach of the general public until 2023 that was a huge profit taking window for congressional representatives. “Skyrizi” which is new in 2010 in 2019 is priced around “$15,000” for a 12 months kit which is 5 or 6 shots. “Humira” is injection and pill form. “Skyrizi” gets rid of 90% of psoriasis with the very first two shots which are 4 weeks apart. “Skyrizi” will remain priced very good until about 2039 when it has a 20 year patent.

When Humira comes from patent in 2023 it’ll send the manufacturing of it to the generic drug companies and drop the purchase price to advertise value which may mean everyone on Medicaid and Medicare may have an opportunity to be treated with it. All biological drug manufacturers will be forced to drop their prices and also to a fair level because ALL doctors will direct their patents to Humira leaving other drug companies with something that can not be sold because of price. In “India” a generic type of “Humira” has been manufactured and the monthly cost is only $400 which is only down a few hundred from the discounted prices in the U.S.. After “Humira” goes off patent in the U.S. even the generic “India” brand will fall in price even further.

I read it might cost a drug company over a million dollars to produce a drug but this really is “Bull Hicky” ;.For starters think a drug company isn’t a drug company with out a team of researchers. In reality a drug company is only researchers. A drug company after it starts building a make money from the drugs they manufactured in the very first place needs to budget for a lasting research team to produce future drug profits. The study team gets its paychecks from previous released drug sales always and forever and NO recouping of costs for the development of a brand new drug is ever needed. A drug company is really a huge laboratory full of scientists that get paid regularly to produce new drugs and do constant experiments. No extra financial outputs are getting on to drive drug prices through the roof.

Popular new releases of drugs are only total profit magnets for drug companies and congressional representatives. It’s like town or city your home is to make you imagine that the cost to deal with a concern will exceed the taxes already collected to fund the staff and resources to deal with the issues that are already funded.

The “Stock Act” was enacted on April 4th, 2012 which required every person in congress to create their investment transactions on their websites within 45 days of creating them for public viewing. Congressional representatives do not want their investments viewed nevertheless when public demand dictated that it become law to own their investments made public they had to provide into people demand and folded to it. After having a year congress went against public demand on April 15th 2013 and voted to kill the areas of regulations that would make their investments public. Congress couldn’t fulfill themselves at the cost of U.S. Citizens with riches galore through insider trading which they believe they’ve the right to accomplish since there’s no legal entity that will punish them.

As Effective Drug Markets Grow Any Drugs Under Patents Sore In Price To The Point Only The Wealthy Can Afford Them. In 2012 The Drug Companies Decided Psoriasis Biological’s Were A Profit Maker In A Fast Growing Market. The Move Was Made To Raise The Prices So Extreme Profits Could Be Realized Through There Patent Monopoly Scheme Of Marketing To The Rich

Biological psoriasis drugs were priced lower in 2012 and insurance companies covered them if an inexpensive deductible was paid by someone who had an excellent job. After the marketplace for biological,s started to develop the marketplace became hijacked by the wealthy as a means to improve their personal values by increasing the costs and marketing these drugs to the wealthy and themselves that are the wealthy for massive profit taking. People who were getting their psoriasis drugs covered through their insurance companies were being dropped off their insurance plans. Even though insurance carriers covered biological’s before 2012 low income Medicaid and Medicare patients still did not have use of these drugs. Medicare Part D prescription plan pays the bulk of cost however the copay is $1200 to $5000 dollars which means most Medicare patients do not have use of biological’s.

There’s no other way you can look at it. “Epipen’s” were getting the same treatment, these were introduced at a lowered price then hijacked for sale simply to the wealthy which may produce high profits with decreased production costs. I keep running into the hearing aid issues that were suppose to own been priced into the thousands of dollars then being reduced to under $700 which is still to expensive and a world of massive profit taking. Advanced computer parts are cheaper than hearing aids?

With one of these drug companies as has been any business who holds a monopoly on any needed or popular product through government mandate the larger prices only the wealthy can pay are dictated which means less production is likely to be needed that results in lower production costs and the same or older profit levels are kept. Production at market demand means higher manufacturing costs with lower profit margins.

Leave a Reply

Your email address will not be published.